ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant <i>M. abscessus</i> in caseum surrogate

Min Xie, Uday S. Ganapathy, Tian Lan, Paulina Osiecki, Jansy P. Sarathy, Véronique Dartois, Courtney C. Aldrich, Thomas Dick

Antimicrobial Agents and Chemotherapy · 2023 · 14 citations · 21 references

DOIFull text

Open access

Concepts

Abstract

ABSTRACT Necrotic lesions and cavities filled with caseum are a hallmark of mycobacterial pulmonary disease. Bronchocavitary Mycobacterium abscessus disease is associated with poor treatment outcomes. In caseum surrogate, M. abscessus entered an extended stationary phase showing tolerance to killing by most current antibiotics, suggesting that caseum persisters contribute to the poor performance of available treatments. Novel ADP-ribosylation-resistant rifabutin analogs exhibited bactericidal activity against these M. abscessus persisters at concentrations achievable by rifamycins in caseum.

References

21